Search

Your search keyword '"Giorda, C"' showing total 228 results

Search Constraints

Start Over You searched for: Author "Giorda, C" Remove constraint Author: "Giorda, C"
228 results on '"Giorda, C"'

Search Results

3. Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus

4. Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus

5. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis

6. Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis

9. A prediction model to assess the risk of egfr loss in patients with type 2 diabetes and preserved kidney function: The amd annals initiative

12. The implementation of international standardization of glycated hemoglobin. A “red-letter-day” for glycated hemoglobin in Italy: 1/1/11 Italian Recommendations of GLAD Working Group (A1c delegates WG)

15. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

16. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences

17. Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study

18. Continuous Subcutaneous Insulin Infusion in Italy: Third National Survey

22. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences

23. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences

24. Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

28. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial

32. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

34. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

35. Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale]

36. Continuous subcutaneous insulin infusion in Italy: Third national survey

37. La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale

38. Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study

39. Sexual dysfunction in type 2 diabetes at diagnosis: Progression over time and drug and non-drug correlated factors

40. Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes

41. SEX DISPARITIES IN THE QUALITY OF DIABETES CARE: BIOLOGICAL AND CULTURAL FACTORS MAY PLAY A DIFFERENT ROLE FOR DIFFERENT OUTCOMES: A CROSS-SECTIONAL OBSERVATIONAL STUDY FROM THE AMD ANNALS INITIATIVE

42. Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: The DYDA study

43. Serum uric acid and risk of CKD in type 2 diabetes

44. La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale [Subcutaneous insulin infusion (CSII) in italy: The third national survey]

45. Subcutaneous insulin infusion (CSII) in italy: The third national survey

46. Geografia e pensiero critico

47. Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study

48. AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care

49. Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study

50. Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study

Catalog

Books, media, physical & digital resources